This Viewpoint discusses the development of pediatric-specific reporting guidelines that facilitate transparent reporting of published pediatric clinical trials.
Clinical Practice Guidelines
Saturday, April 19
Latest
- Is Low-Fat Dairy an Appropriate Recommendation for Children?
- Whole-Body Hypothermia for Neonatal Encephalopathy
- Antimicrobial Prophylaxis Use and Outcomes for Children Undergoing Cholecystectomy
- Further Considerations on Corticosteroid Use in Premature Infants—Reply
- Further Considerations on Corticosteroid Use in Premature Infants
- Further Considerations on Corticosteroid Use in Premature Infants
- Postvaccination Immunogenicity Among Pediatric Solid Organ Transplant Recipients
- What Parents Need to Know About Knee Pain in Active Children
- Error in Table
- JAMA Pediatrics
- Childhood Traumatic Brain Injury and Crime in Adolescence
- Congenital Cytomegalovirus Screening Moves Ahead
- Pediatric Obesity Treatment Improves Young Adult Health
- Identifying Correlates of Condom Use Among US Adolescents
- First-Attempt Success in Ultrasound-Guided vs Standard Peripheral Intravenous Catheter Insertion
- Comparative Efficacy of Nonsteroid Immunosuppressive Medications in Childhood Nephrotic Syndrome
- Supporting Low-Income Families’ Access to Summer Health Programs
- Sudden Unexpected Infant Death and Disparities in Infant Mortality in the US, 1999-2022
- What Parents Should Know About Allergic Rhinitis
- JAMA Pediatrics
- It Is Time to Get Political for Children
- Multilingual Research Strategies to Enhance Equity
- Errors in Table, Figure Title, Byline, and Author Affiliations
- What Parents Should Know About Children With Multiple Languages
- Low Uptake of Lipid Screening
- Occurrence and Time of Onset of Intraventricular Hemorrhage in Preterm Neonates
- More on Neighborhood Food Access by Child Body Mass Index and Obesity—Reply
- More on Neighborhood Food Access by Child Body Mass Index and Obesity
- Medicaid and the Promise for Cure
- JAMA Pediatrics
- Systemic Corticosteroids to Prevent Bronchopulmonary Dysplasia
- Consideration of Children in Naloxone Coprescribing Laws
- About Whom Are We Talking—Intellectual and Developmental Disabilities
- The Philadelphia Beverage Tax and Pediatric Weight Outcomes
- Contraception Choice Beyond Efficacy—Reply
- Contraception Choice Beyond Efficacy
- Effects on Body Mass Index After the Philadelphia Beverage Tax
- What Parents Should Know About Naloxone
- JAMA Pediatrics
- Errors in the Results and Table
- Antibiotic Shortage During a Public Health Crisis—The Perfect Storm
- Tenant Right-to-Counsel and Adverse Birth Outcomes in New York, New York
- Developmental Timing of Associations Among Parenting, Brain Architecture, and Mental Health
- Prenatal Cannabis Exposure and Executive Function and Aggressive Behavior at Age 5 Years
- Optimal Oxygen Levels for Preterm Infant Resuscitation—Reply
- Optimal Oxygen Levels for Preterm Infant Resuscitation
- Prenatal Cannabis Exposure—An Intergenerational Risk Marker for Neurodevelopment
- What Parents Should Know About Crying in Infants
- Day Care Attendance and Risk of Type 1 Diabetes
- JAMA Pediatrics
- Trends in Location of Death for Individuals With Pediatric Cancer
- The Child Tax Credit—Tax Policy as Health Policy